What genetic mutations are associated with Lynch syndrome, and how do they contribute to cancer risk?

Lynch syndrome is associated with mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM genes, leading to defective mismatch repair and increased cancer risk. Genetic testing is pivotal for risk management and guiding tailored cancer surveillance and treatment strategies.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-14
DOI
https://doi.org/10.5281/zenodo.24234983
Primary Topic
Genetic factors in colorectal cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What genetic mutations are associated with Lynch syndrome, and how do they contribute to cancer risk?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Genetic factors in colorectal cancer
article

What genetic mutations are associated with Lynch syndrome, and how do they contribute to cancer risk?

Tripdatabase
article en

Abstract

Lynch syndrome is associated with mutations in MLH1, MSH2, MSH6, PMS2, and EPCAM genes, leading to defective mismatch repair and increased cancer risk. Genetic testing is pivotal for risk management and guiding tailored cancer surveillance and treatment strategies.

Zenodo (CERN European Organization for Nuclear Research)
Genetic factors in colorectal cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon